Pulse oximetry screening for critical congenital heart defects
- PMID: 29494750
- PMCID: PMC6494396
- DOI: 10.1002/14651858.CD011912.pub2
Pulse oximetry screening for critical congenital heart defects
Abstract
Background: Health outcomes are improved when newborn babies with critical congenital heart defects (CCHDs) are detected before acute cardiovascular collapse. The main screening tests used to identify these babies include prenatal ultrasonography and postnatal clinical examination; however, even though both of these methods are available, a significant proportion of babies are still missed. Routine pulse oximetry has been reported as an additional screening test that can potentially improve detection of CCHD.
Objectives: • To determine the diagnostic accuracy of pulse oximetry as a screening method for detection of CCHD in asymptomatic newborn infants• To assess potential sources of heterogeneity, including:○ characteristics of the population: inclusion or exclusion of antenatally detected congenital heart defects;○ timing of testing: < 24 hours versus ≥ 24 hours after birth;○ site of testing: right hand and foot (pre-ductal and post-ductal) versus foot only (post-ductal);○ oxygen saturation: functional versus fractional;○ study design: retrospective versus prospective design, consecutive versus non-consecutive series; and○ risk of bias for the "flow and timing" domain of QUADAS-2.
Search methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 2) in the Cochrane Library and the following databases: MEDLINE, Embase, the Cumulative Index to Nursing and Allied Health Literature (CINAHL), and Health Services Research Projects in Progress (HSRProj), up to March 2017. We searched the reference lists of all included articles and relevant systematic reviews to identify additional studies not found through the electronic search. We applied no language restrictions.
Selection criteria: We selected studies that met predefined criteria for design, population, tests, and outcomes. We included cross-sectional and cohort studies assessing the diagnostic accuracy of pulse oximetry screening for diagnosis of CCHD in term and late preterm asymptomatic newborn infants. We considered all protocols of pulse oximetry screening (eg, different saturation thresholds to define abnormality, post-ductal only or pre-ductal and post-ductal measurements, test timing less than or greater than 24 hours). Reference standards were diagnostic echocardiography (echocardiogram) and clinical follow-up, including postmortem findings, mortality, and congenital anomaly databases.
Data collection and analysis: We extracted accuracy data for the threshold used in primary studies. We explored between-study variability and correlation between indices visually through use of forest and receiver operating characteristic (ROC) plots. We assessed risk of bias in included studies using the QUADAS-2 tool. We used the bivariate model to calculate random-effects pooled sensitivity and specificity values. We investigated sources of heterogeneity using subgroup analyses and meta-regression.
Main results: Twenty-one studies met our inclusion criteria (N = 457,202 participants). Nineteen studies provided data for the primary analysis (oxygen saturation threshold < 95% or ≤ 95%; N = 436,758 participants). The overall sensitivity of pulse oximetry for detection of CCHD was 76.3% (95% confidence interval [CI] 69.5 to 82.0) (low certainty of the evidence). Specificity was 99.9% (95% CI 99.7 to 99.9), with a false-positive rate of 0.14% (95% CI 0.07 to 0.22) (high certainty of the evidence). Summary positive and negative likelihood ratios were 535.6 (95% CI 280.3 to 1023.4) and 0.24 (95% CI 0.18 to 0.31), respectively. These results showed that out of 10,000 apparently healthy late preterm or full-term newborn infants, six will have CCHD (median prevalence in our review). Screening by pulse oximetry will detect five of these infants as having CCHD and will miss one case. In addition, screening by pulse oximetry will falsely identify another 14 infants out of the 10,000 as having suspected CCHD when they do not have it.The false-positive rate for detection of CCHD was lower when newborn pulse oximetry was performed longer than 24 hours after birth than when it was performed within 24 hours (0.06%, 95% CI 0.03 to 0.13, vs 0.42%, 95% CI 0.20 to 0.89; P = 0.027).Forest and ROC plots showed greater variability in estimated sensitivity than specificity across studies. We explored heterogeneity by conducting subgroup analyses and meta-regression of inclusion or exclusion of antenatally detected congenital heart defects, timing of testing, and risk of bias for the "flow and timing" domain of QUADAS-2, and we did not find an explanation for the heterogeneity in sensitivity.
Authors' conclusions: Pulse oximetry is a highly specific and moderately sensitive test for detection of CCHD with very low false-positive rates. Current evidence supports the introduction of routine screening for CCHD in asymptomatic newborns before discharge from the well-baby nursery.
Conflict of interest statement
Maria Nieves Plana: none to declare.
Javier Zamora: none to declare.
Gautham Suresh: none to declare.
Luis Fernandes‐Pineda: none to declare.
Shakila Thangaratinam: an author of one of the primary studies ‐ Ewer 2011.
Andrew K. Ewer: an author of one of the primary studies ‐ Ewer 2011.
Figures
Comment in
-
Commentary on "Pulse Oximetry Screening for Critical Congenital Heart Defects".Neonatology. 2020;117(1):4-7. doi: 10.1159/000496621. Epub 2019 May 27. Neonatology. 2020. PMID: 31132770 No abstract available.
References
References to studies included in this review
Arlettaz 2006 {published data only}
-
- Arlettaz R, Bauschatz AS, Monkhoff M, Essers B, Bauersfeld U. The contribution of pulse oximetry to the early detection of congenital heart disease in newborns. European Journal of Pediatrics 2006;165(2):94‐8. [PUBMED: 10.1007/s00431‐005‐0006‐y; PUBMED: 16211399] - PubMed
Bakr 2005 {published data only}
Bhola 2014 {published data only}
de‐Wahl Granelli 2009 {published data only}
-
- de‐Wahl Granelli A, Wennergren M, Sandberg K, Mellander M, Bejlum C, Inganas L, et al. Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns. BMJ (Clinical Research Ed.) 2009;338:a3037. [DOI: 10.1136/bmj.a3037; PUBMED: 19131383] - DOI - PMC - PubMed
Ewer 2011 {published data only}
-
- Ewer AK, Middleton LJ, Furmston AT, Bhoyar A, Daniels JP, Thangaratinam S, et al. PulseOx Study Group. Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): a test accuracy study. Lancet 2011;378(9793):785‐94. [DOI: 10.1016/S0140-6736(11)60753-8; PUBMED: 21820732] - DOI - PubMed
Gomez‐Rodriguez 2015 {published data only}
-
- Gomez‐Rodriguez G, Quezada‐Herrera A, Amador‐Licona N, Carballo‐Magdaleno D, Rodriguez‐Mejia EJ, Guizar‐Mendoza JM. Pulse oximetry as a screening test for critical congenital heart disease in term newborns. Revista de Investigacion Clinica 2015;67(2):130‐4. [PUBMED: 25938847] - PubMed
Jones 2016 {published data only}
Klausner 2017 {published data only}
Koppel 2003 {published data only}
-
- Koppel RI, Druschel CM, Carter T, Goldberg BE, Mehta PN, Talwar R, et al. Effectiveness of pulse oximetry screening for congenital heart disease in asymptomatic newborns. Pediatrics 2003;111(3):451‐5. [PUBMED: 12612220] - PubMed
Meberg 2008 {published data only}
Oakley 2015 {published data only}
-
- Oakley JL, Soni NB, Wilson D, Sen S. Effectiveness of pulse‐oximetry in addition to routine neonatal examination in detection of congenital heart disease in asymptomatic newborns. Journal of Maternal‐Fetal & Neonatal Medicine 2015;28(14):1736‐9. [DOI: 10.3109/14767058.2014.967674; PUBMED: 25241768] - DOI - PubMed
Ozalkaya 2016 {published data only}
Richmond 2002 {published data only}
Riede 2010 {published data only}
-
- Riede FT, Worner C, Dahnert I, Mockel A, Kostelka M, Schneider P. Effectiveness of neonatal pulse oximetry screening for detection of critical congenital heart disease in daily clinical routine ‐ results from a prospective multicenter study. European Journal of Pediatrics 2010;169(8):975‐81. [DOI: 10.1007/s00431-010-1160-4; PUBMED: 20195633] - DOI - PMC - PubMed
Rosati 2005 {published data only}
Sendelbach 2008 {published data only}
Singh 2014 {published data only}
Turska 2012 {published data only}
-
- Turska Kmiec A, Borszewska Kornacka MK, Blaz W, Kawalec W, Zuk M. Early screening for critical congenital heart defects in asymptomatic newborns in Mazovia province: experience of the POLKARD pulse oximetry programme 2006‐2008 in Poland. Kardiologia Polska 2012;70(4):370‐6. [22528711] - PubMed
Van Niekerk 2016 {published data only}
-
- Niekerk AM, Cullis RM, Linley LL, Zuhlke L. Feasibility of pulse oximetry pre‐discharge screening implementation for detecting critical congenital heart lesions in newborns in a secondary level maternity hospital in the Western Cape, South Africa: The 'POPSICLe' study. South African Medical Journal 2016;106(8):817‐21. [PUBMED: 27499412] - PubMed
Zhao 2014 {published data only}
-
- Zhao QM, Ma XJ, Ge XL, Liu F, Yan WL, Wu L, et al. Neonatal Congenital Heart Disease Screening Group. Pulse oximetry with clinical assessment to screen for congenital heart disease in neonates in China: a prospective study. Lancet 2014;384(9945):747‐54. [DOI: 10.1016/S0140-6736(14)60198-7; PUBMED: 24768155] - DOI - PubMed
Zuppa 2015 {published data only}
-
- Zuppa AA, Riccardi R, Catenazzi P, D'Andrea V, Cavani M, D'Antuono A, et al. Clinical examination and pulse oximetry as screening for congenital heart disease in low‐risk newborn. Journal of Maternal‐Fetal & Neonatal Medicine 2015;28(1):7‐11. [DOI: 10.3109/14767058.2014.899573; PUBMED: 24588079] - DOI - PubMed
References to studies excluded from this review
Andrews 2014 {published data only}
Ewer 2012a {published data only}
-
- Ewer AK, Furmston AT, Middleton LJ, Deeks JJ, Daniels JP, Pattison HM, et al. Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost‐effectiveness. Health Technology Assessment (Winchester, England) 2012;16(2):v‐xiii, 1‐184. [DOI: 10.3310/hta16020; PUBMED: 22284744] - DOI - PubMed
Hoke 2002 {published data only}
John 2016 {published data only}
-
- John C, Phillips J, Hamilton C, Lastliger A. Implementing universal pulse oximetry screening in West Virginia: findings from year one. West Virginia Medical Journal 2016;112(4):42‐6. [PUBMED: 27491102] - PubMed
Kardasevic 2016 {published data only}
Kochilas 2013 {published data only}
Lhost 2014 {published data only}
Meberg 2009 {published data only}
Movahedian 2016 {published data only}
Narayen 2016a {published data only}
-
- Narayen IC, Blom NA, Bourgonje MS, Haak MC, Smit M, Posthumus F, et al. Pulse oximetry screening for critical congenital heart disease after home birth and early discharge. Journal of Pediatrics 2016;170:188‐92.e1. [PUBMED: 10.1016/j.jpeds.2015.12.004] - PubMed
Prudhoe 2013 {published data only}
Reich 2003 {published data only}
Reich 2008 {published data only}
-
- Reich JD, Connolly B, Bradley G, Littman S, Koeppel W, Lewycky P, et al. The reliability of a single pulse oximetry reading as a screening test for congenital heart disease in otherwise asymptomatic newborn infants. Pediatric Cardiology 2008;29(5):885‐9. [DOI: 10.1007/s00246-008-9214-3; PUBMED: 18347842] - DOI - PubMed
Reich 2008a {published data only}
-
- Reich JD, Connolly B, Bradley G, Littman S, Koeppel W, Lewycky P, et al. Reliability of a single pulse oximetry reading as a screening test for congenital heart disease in otherwise asymptomatic newborn infants: the importance of human factors. Pediatric Cardiology 2008;29(2):371‐6. [DOI: 10.1007/s00246-007-9105-z; PUBMED: 17932712] - DOI - PubMed
Riede 2009 {published data only}
Ruangritnamchai 2007 {published data only}
Saha 2014 {published data only}
-
- Saha A, Mathew JL, Chawla D, Kumar D. How useful is pulse oximetry for screening of congenital heart disease in newborns?. Indian Pediatrics 2014;51(11):913‐5. [PUBMED: 25432224] - PubMed
Saxena 2015 {published data only}
-
- Saxena A, Mehta A, Ramakrishnan S, Sharma M, Salhan S, Kalaivani M, et al. Pulse oximetry as a screening tool for detecting major congenital heart defects in Indian newborns. Archives of Disease in Childhood. Fetal and Neonatal Edition 2015;100(5):F416‐21. [DOI: 10.1136/archdischild-2014-307485; PUBMED: 26038347] - DOI - PubMed
Schena 2017 {published data only}
-
- Schena F, Picciolli I, Agosti M, Zuppa AA, Zuccotti G, Parola L, et al. Neonatal Cardiology Study Group of the Italian Society of Neonatology. Perfusion index and pulse oximetry screening for congenital heart defects. Journal of Pediatrics 2017;183:74‐9.e1. [DOI: 10.1016/j.jpeds.2016.12.076; PUBMED: 28153478] - DOI - PubMed
Studer 2014 {published data only}
Taksande 2013 {published data only}
Tautz 2010 {published data only}
Tsao 2016 {published data only}
Vaidyanathan 2011 {published data only}
-
- Vaidyanathan B, Sathish G, Mohanan ST, Sundaram KR, Warrier KK, Kumar RK. Clinical screening for congenital heart disease at birth: a prospective study in a community hospital in Kerala. Indian Pediatrics 2011;48(1):25‐30. [PUBMED: 20972295] - PubMed
Valmari 2006 {published data only}
-
- Valmari P, Jauhola R, Leskinen M, Heikinheimo M. [Oxygen saturation to detect asymptomatic congenital heart disease of newborns] [Vastasyntyneen kavalat sydanviat‐‐aika aloittaa happikyllasteisyysseulonta?]. Duodecim; Laaketieteellinen Aikakauskirja 2006;122(2):173‐6. [PUBMED: 16509060] - PubMed
Additional references
Abu‐Harb 1994
Abu‐Harb 1994a
Allan 1986
Balshem 2011
-
- Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology 2011;64(4):401‐6. [PUBMED: 21208779] - PubMed
Boneva 2001
-
- Boneva RS, Botto LD, Moore CA, Yang Q, Correa A, Erickson JD. Mortality associated with congenital heart defects in the United States: trends and racial disparities, 1979‐1997. Circulation 2001;103(19):2376‐81. [PUBMED: 11352887] - PubMed
Botto 2001
-
- Botto LD, Correa A, Erickson JD. Racial and temporal variations in the prevalence of heart defects. Pediatrics 2001;107(3):E32. [PUBMED: 11230613] - PubMed
Brown 2001
-
- Brown JW, Park HJ, Turrentine MW. Arterial switch operation: factors impacting survival in the current era. Annals of Thoracic Surgery 2001;71(6):1978‐84. [PUBMED: 11426778] - PubMed
Brown 2006
Bull 1999
-
- Bull C. Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK. British Paediatric Cardiac Association. Lancet 1999;354(9186):1242‐7. [PUBMED: 10520632] - PubMed
Carvalho 2002
Cawsey 2016
-
- Cawsey MJ, Noble S, Cross‐Sudworth F, Ewer AK. Feasibility of pulse oximetry screening for critical congenital heart defects in homebirths. Archives of Disease in Childhood. Fetal and Neonatal Edition 2016;101(4):F349‐51. [PUBMED: 26915671] - PubMed
Chang 2008
Chew 2007
Chu 2006
-
- Chu H, Cole SR. Bivariate meta‐analysis of sensitivity and specificity with sparse data: a generalized linear mixed model approach. Journal of Clinical Epidemiology 2006; Vol. 59, issue 12:1331‐2; author reply 1332‐3. - PubMed
de‐Wahl Granelli 2014
Ewer 2012b
Ewer 2013
Ewer 2014
Ewer 2016
Franklin 2002
Garne 2001
GRADEpro GDT [Computer program]
-
- GRADEproGDT [Computer program]. Version accessed March 2017. GRADE Handbook. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. Available from gradepro.org.
Hall 1999
Han 2013
Heron 2007
-
- Heron MP, Smith BL. Deaths: leading causes for 2003. National Vital Statistics Reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System 2007;55(10):1‐92. [17408087] - PubMed
Hultcrantz 2017
Iyengar 2014
Knapp 2010
-
- Knapp AA, Metterville DR, Kemper AR, Prosser L, Perrin JM. Evidence review: critical congenital cyanotic heart disease. Prepared for: Maternal And Child Health Bureau. Massachusetts General Hospital, Center for Child and Adolescent Health Policy and Health Resources and Services Administration (HRSA), U.S. Department of Health and Human Services (DHHS) 2010. [https://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders/...
Knowles 2005
-
- Knowles R, Griebsch I, Dezateux C, Brown J, Bull C, Wren C. Newborn screening for congenital heart defects: a systematic review and cost‐effectiveness analysis. Health Technology Assessment 2005;9(44):1‐152, iii‐iv. [PUBMED: 16297355] - PubMed
Kuelling 2009
-
- Kuelling B, Arlettaz Mieth R, Bauersfeld U, Balmer C. Pulse oximetry screening for congenital heart defects in Switzerland: most but not all maternity units screen their neonates. Swiss Medical Weekly 2009;139(47‐48):699‐704. [DOI: ; PUBMED: 20047132] - PubMed
Leeflang 2008
Lloyd‐Jones 2009
-
- Lloyd‐Jones D, Adams R, Carnethon M, Simone G, Ferguson TB, Flegal K, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics ‐ 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009;119(3):480‐6. [DOI: 10.1161/CIRCULATIONAHA.108.191259; PUBMED: 19171871] - DOI - PubMed
Macaskill 2010
-
- Macaskill P, Gatsonis C, Deeks JJ, Harbord RM, Takwoingi Y. Chapter 10: Analysing and Presenting Results. In: Deeks JJ, Bossuyt PM, Gatsonis C (editors), Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0. The Cochrane Collaboration, 2010. Available from srdta.cochrane.org.
Mahle 2008
Mahle 2009
-
- Mahle WT, Newburger JW, Matherne GP, Smith FC, Hoke TR, Koppel R, et al. American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, and Interdisciplinary Council on Quality of Care and Outcomes Research, American Academy of Pediatrics Section on Cardiology, Cardiac Surgery. Committee on Fetus and Newborn. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP. Pediatrics 2009;124(2):823‐36. [DOI: 10.1542/peds.2009-1397; PUBMED: 19581259] - DOI - PubMed
Mahle 2012
-
- Mahle WT, Martin GR, Beekman RH 3rd, Morrow WR, Section on Cardiology and Cardiac Surgery Executive Committee. Endorsement of Health and Human Services recommendation for pulse oximetry screening for critical congenital heart disease. Pediatrics 2012;129(1):190‐2. [DOI: 10.1542/peds.2011-3211; PUBMED: 22201143] - DOI - PubMed
Manzoni 2017
Mellander 2006
Narayen 2016b
-
- Narayen IC, Blom NA, Ewer AK, Vento M, Manzoni P, Pas AB. Aspects of pulse oximetry screening for critical congenital heart defects: when, how and why. Archives of Disease in Childhood. Fetal and Neonatal Edition 2016;101:F162–7. - PubMed
Narayen 2017
O'Donnell 2007
Office of National Statistics, 2015
-
- Office of National Statistics (ONS). Statistical bulletin: deaths registered in England and Wales: 2014. Deaths, stillbirths and infant mortality including death rates, causes, age, and area of residence. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarri... 2015.
Peterson 2013
Powell 2013
-
- Powell R, Pattison HM, Bhoyar A, Furmston AT, Middleton LJ, Daniels JP, et al. Pulse oximetry screening for congenital heart defects in newborn infants: an evaluation of acceptability to mothers. Archives of Disease in Childhood. Fetal and Neonatal Edition 2013;98(1):F59‐63. [DOI: 10.1136/fetalneonatal-2011-301225; PUBMED: 22611113] - DOI - PubMed
Reitsma 2005
-
- Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. Journal of Clinical Epidemiology 2005;58(10):982‐90. [DOI: 10.1016/j.jclinepi.2005.02.022; PUBMED: 16168343] - DOI - PubMed
RevMan 2014 [Computer program]
-
- Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Roberts 2012
-
- Roberts TE, Barton PM, Auguste PE, Middleton LJ, Furmston AT, Ewer AK. Pulse oximetry as a screening test for congenital heart defects in newborn infants: a cost‐effectiveness analysis. Archives of Disease in Childhood 2012;97(3):221‐6. [DOI: 10.1136/archdischild-2011-300564; PUBMED: 22247242] - DOI - PubMed
SAS Institute Inc. 2004
-
- SAS Institute Inc. What’s New in SAS® 9.0, 9.1, 9.1.2, and 9.1.3. SAS OnlineDoc® 9.1.3. Cary, NC 2004. [https://support.sas.com/documentation/onlinedoc/91pdf/sasdoc_913/whatsne...
Schunemann 2008
-
- Schunemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE, et al. GRADE Working Group. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ (Clinical Research Ed.) 2008;336(7653):1106‐10. [DOI: 10.1136/bmj.39500.677199.AE; PUBMED: 18483053] - DOI - PMC - PubMed
Suresh 2013
Takwoingi 2010
-
- Takwoingi Y, Deeks JJ. MetaDAS: A SAS macro for meta‐analysis of diagnostic accuracy studies. Quick reference and worked example. Available from http://srdta.cochrane.org/ Version 1.3. Accessed July 2010.
Tegnander 2006
Thangaratinam 2007
-
- Thangaratinam S, Daniels J, Ewer AK, Zamora J, Khan KS. Accuracy of pulse oximetry in screening for congenital heart disease in asymptomatic newborns: a systematic review. Archives of Disease in Childhood. Fetal and Neonatal Edition 2007;92(3):F176‐80. [DOI: 10.1136/adc.2006.107656; PUBMED: 17344253] - DOI - PMC - PubMed
Thangaratinam 2012
Tworetzky 2001
-
- Tworetzky W, McElhinney DB, Reddy VM, Brook MM, Hanley FL, Silverman NH. Improved surgical outcome after fetal diagnosis of hypoplastic left heart syndrome. Circulation 2001;103(9):1269‐73. [PUBMED: 11238272] - PubMed
Westin 2006
-
- Westin M, Saltvedt S, Bergman G, Kublickas M, Almstrom H, Grunewald C, et al. Routine ultrasound examination at 12 or 18 gestational weeks for prenatal detection of major congenital heart malformations? A randomised controlled trial comprising 36,299 fetuses. BJOG 2006;113(6):675‐82. [DOI: 10.1111/j.1471-0528.2006.00951.x; PUBMED: 16709210] - DOI - PubMed
Whiting 2011
-
- Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS‐2 Group. QUADAS‐2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine 2011;155(8):529‐36. [DOI: 10.7326/0003-4819-155-8-201110180-00009; PUBMED: 22007046 ] - DOI - PubMed
Wren 1999
Wren 2008
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
